Seattle BioMed

Andrew V. Oleinikov, Ph.D.

Principal Scientist/Independent Lab, Seattle Biomedical Research Institute
Area of Expertise: malaria

Accomplishments & Collaborations

Accomplishments

  • Identified a number of vaccine candidates in pregnancy malaria and severe malaria using high throughput methods including functional protein arrays
  • Developed quantitative functional protein microarrays based on various platforms for high throughput drug, ligand, and antibody screening 
  • Developing a vaccine against pregnancy malaria for pre-clinical studies 
  • Initiated studies of malaria nucleic acid maintenance apparatus (miRNA/siRNA/splicing) and sub-telomeric gene silencing phenomenon using small molecule drugs
  • Published seven papers in peer-reviewed journals. One of the papers highlighted as a “hot paper” in Nature Reviews Microbiology (November 2007)
  • Published a book chapter on siRNA drugs in “Handbook of Pharmaceutical Biotechnology”
  • Filed two patent application (one patent is currently awarded)

Collaborations

  • National Institutes of Health
  • Centers for Disease Control and Prevention
  • University of Washington, Seattle
  • University of California, Davis
  • University of Copenhagen, Copenhagen, Denmark
  • Pasteur Institute, Paris, France
  • Johns Hopkins Malaria Research Institute
  • Sharp Laboratories of America